| Report ID | 278098 |
| Drug Identification Number | 02551268 |
| Brand name | M-PROGESTERONE |
| Common or Proper name | M-Progesterone |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGESTERONE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | bouteilles de 100 |
| ATC code | G03FA |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2026-01-19 |
| Estimated end date | 2026-03-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-13 | French | Compare |
| v3 | 2026-02-13 | English | Compare |
| v2 | 2026-02-13 | French | Compare |
| v1 | 2026-02-13 | English | Compare |
Showing 1 to 4 of 4